Llama antibodies open new therapeutic avenues against schizophrenia

While current treatments for schizophrenia—a mental illness affecting 1% of the world’s population—can reduce certain symptoms, they have little effect on the cognitive deficits affecting the daily life of patients.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup